ScienceLatest
GSK advances ovarian cancer drug mo-rez
GSK is progressing with its ovarian cancer drug mo-rez, aiming to improve treatment options. This development could significantly impact patients battling this challenging disease.
0 upvotes
What happened
GSK is progressing with its ovarian cancer drug mo-rez, aiming to improve treatment options.
Why it matters
This development could significantly impact patients battling this challenging disease.